CRISPR Therapeutics AG (CRSP) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

CRSP is expected to report earnings to fall 5.37% to -140 cents per share on October 30

CRISPR Therapeutics AG CRSP Stock Earnings Reports

Q3'24

Est.

$-1.41

Q2'24

Missed

by $0.06

Q1'24

Missed

by $0.08

Q4'23

Beat

by $1.05

Q3'23

Beat

by $0.58

The last earnings report on August 05 showed earnings per share of -149 cents, missing the estimate of -142 cents. With 869.89K shares outstanding, the current market capitalization sits at 4.03B.

View a ticker or compare two or three

Compare

CRSP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CRSP
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CRSP (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of gene-based medicines

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

Baarerstrasse 14

Phone

+41 415613277

Employees

407

Web

https://www.crisprtx.com